Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Local Recurrence of Malignant Tumor of Rectum”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT00004911
What this trial is testing

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more
Northwestern University
Not applicableStudy completedNCT07353567
What this trial is testing

Long-term Outcomes and Risk Factors of Local Re-Recurrence in Patients

Who this might be right for
Local Re-Recurrence of Malignant Tumor of RectumLocal Recurrence of Malignant Tumor of Rectum
Sixth Affiliated Hospital, Sun Yat-sen University 298
Not applicableNot Yet RecruitingNCT06896578
What this trial is testing

Latitude - Lateral Lymph Node Attitude Study

Who this might be right for
Rectal Neoplasm Malignant
Sahlgrenska University Hospital 1,000
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Not applicableStudy completedNCT00910143
What this trial is testing

Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
Insel Gruppe AG, University Hospital Bern 194
Large-scale testing (Phase 3)Study completedNCT00003287
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 554
Not applicableUnknownNCT03098108
What this trial is testing

Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer

Who this might be right for
Previously Irradiated Recurrent Rectal Cancer
Samsung Medical Center 24
Not applicableStudy completedNCT00084773
What this trial is testing

Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04889742
What this trial is testing

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Who this might be right for
Recurrent CancerProstate CancerCervical Cancer+7 more
Charite University, Berlin, Germany 110
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05078515
What this trial is testing

Multicenter Validation of the PREDICT Score

Who this might be right for
Rectal Cancer
Mansoura University 262
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT07512232
What this trial is testing

Intraoperative Rectal Lavage to Prevent Local Recurrence After Laparoscopic Mid-to-Low Rectal Cancer Resection: A Multicenter Randomized Trial

Who this might be right for
Middle and Low Rectal CancerRectal Cancer Surgery
Sun Yat-sen University 1,598
Not applicableUnknownNCT04969107
What this trial is testing

Abdominal or Transanal TME for Rectal Cancer Therapy

Who this might be right for
SurvivalPostoperative MorbidityMortality+1 more
Cantonal Hospital of St. Gallen 300
Not applicableUnknownNCT03042000
What this trial is testing

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 1,200
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Next Page